GlassScriptPhysician profile
Aneesa Husain
NPI 1689923666
$920.12
in general payments reported to CMS, 2019-2025
12 companies · $5.59 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $48.71 · 2022: $357 · 2023: $98.80 · 2024: $410 · 2025: $5.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $514.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $462.17 | 2022-2024 | Menopur |
| Organon LLC | $102.16 | 2023-2025 | Ganirelix Acetate, Pregnyl, Follistim Aq |
| 180 Medical, INC. | $58.34 | 2021-2022 | |
| Coloplast Corp | $55.74 | 2023-2024 | Speedicath |
| Abbvie INC. | $55.23 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $46.66 | 2022 | |
| Astellas Pharma US INC | $37.99 | 2022 | |
| Urovant Sciences INC | $30.50 | 2022 | |
| Merck Sharp & Dohme LLC | $21.80 | 2022 | |
| Blue Earth Diagnostics | $17.74 | 2022 | |
| Tolmar, INC. | $16.55 | 2024 | |
| Dendreon Pharmaceuticals LLC | $15.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aneesa Husain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.